Gilead Sciences Inc (GILD)
66.68
+0.52
(+0.79%)
USD |
NASDAQ |
Apr 19, 15:57
Gilead Sciences Profit Margin (Quarterly): 20.09% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.09% |
| September 30, 2023 | 30.92% |
| June 30, 2023 | 15.84% |
| March 31, 2023 | 15.90% |
| December 31, 2022 | 22.20% |
| September 30, 2022 | 25.40% |
| June 30, 2022 | 18.27% |
| March 31, 2022 | 0.29% |
| December 31, 2021 | 5.27% |
| September 30, 2021 | 34.93% |
| June 30, 2021 | 24.48% |
| March 31, 2021 | 26.92% |
| December 31, 2020 | 20.90% |
| September 30, 2020 | 5.47% |
| June 30, 2020 | -64.92% |
| March 31, 2020 | 27.96% |
| December 31, 2019 | 45.86% |
| September 30, 2019 | -20.79% |
| June 30, 2019 | 33.07% |
| March 31, 2019 | 37.40% |
| December 31, 2018 | 0.05% |
| September 30, 2018 | 37.47% |
| June 30, 2018 | 32.17% |
| March 31, 2018 | 30.23% |
| December 31, 2017 | -64.97% |
| Date | Value |
|---|---|
| September 30, 2017 | 41.74% |
| June 30, 2017 | 43.03% |
| March 31, 2017 | 41.54% |
| December 31, 2016 | 42.46% |
| September 30, 2016 | 44.40% |
| June 30, 2016 | 44.97% |
| March 31, 2016 | 45.75% |
| December 31, 2015 | 55.06% |
| September 30, 2015 | 55.46% |
| June 30, 2015 | 54.49% |
| March 31, 2015 | 57.06% |
| December 31, 2014 | 47.68% |
| September 30, 2014 | 45.20% |
| June 30, 2014 | 55.94% |
| March 31, 2014 | 44.55% |
| December 31, 2013 | 25.37% |
| September 30, 2013 | 28.34% |
| June 30, 2013 | 27.92% |
| March 31, 2013 | 28.53% |
| December 31, 2012 | 29.48% |
| September 30, 2012 | 27.84% |
| June 30, 2012 | 29.58% |
| March 31, 2012 | 19.36% |
| December 31, 2011 | 30.23% |
| September 30, 2011 | 34.93% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-64.92%
Minimum
Jun 2020
45.86%
Maximum
Dec 2019
15.16%
Average
20.90%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 9.36% |
| Johnson & Johnson | 25.04% |
| Eli Lilly and Co | 23.41% |
| CymaBay Therapeutics Inc (DELISTED) | -73.51K% |
| Arcus Biosciences Inc | -261.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 26.17% |
| Return on Assets | 9.08% |
| Return on Invested Capital | 12.11% |
| Gross Profit Margin (Quarterly) | 70.62% |
| Operating Margin (Quarterly) | 28.23% |
| Return on Net Operating Assets | 11.88% |